Skip to main content

CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial

Publication ,  Journal Article
Tricoci, P; Chen, E; Neely, ML; Warner, A; Wong, PH; Sinnaeve, P; Wallentin, L; Jennings, LK; Storey, RF; Aylward, PE; White, HD; Held, C ...
Published in: CIRCULATION
November 26, 2013

Duke Scholars

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

November 26, 2013

Volume

128

Issue

22

Location

Dallas, TX

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tricoci, P., Chen, E., Neely, M. L., Warner, A., Wong, P. H., Sinnaeve, P., … Moliterno, D. J. (2013). CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial. CIRCULATION, 128(22).
Tricoci, Pierluigi, Edmond Chen, Megan L. Neely, Amelia Warner, Peggy H. Wong, Peter Sinnaeve, Lars Wallentin, et al. “CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial.” CIRCULATION 128, no. 22 (November 26, 2013).
Tricoci P, Chen E, Neely ML, Warner A, Wong PH, Sinnaeve P, et al. CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial. CIRCULATION. 2013 Nov 26;128(22).
Tricoci, Pierluigi, et al. “CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial.” CIRCULATION, vol. 128, no. 22, LIPPINCOTT WILLIAMS & WILKINS, Nov. 2013.
Tricoci P, Chen E, Neely ML, Warner A, Wong PH, Sinnaeve P, Wallentin L, Jennings LK, Storey RF, Aylward PE, White HD, Van de Werf F, Armstrong PW, Held C, Valgimigli M, Harrington RA, Strony J, Mahaffey KW, Moliterno DJ. CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2013 Nov 26;128(22).

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

November 26, 2013

Volume

128

Issue

22

Location

Dallas, TX

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology